Hamid Aghajan

Prof. Hamid Aghajan

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 March 2021 in BMC Medical Informatics and Decision Making
Verified
Journal Article
Open access
PDF file
ARAlireza Roshanzamir
Alireza Roshanzamir
HAHamid Aghajan
Hamid Aghajan
MBMahdieh Soleymani Baghshah
Mahdieh Soleymani Baghshah
Background: We developed transformer-based deep learning models based on natural language processing for early risk assessment of Alzheimer’s disease from the picture description test.Methods: The lack of large datasets poses the most important limitation for using complex models that do not require feature engineering. Transformer-based pre-trained deep language models have recently made a large leap in NLP research and application. These models are pre-trained on available large datasets to understand natural language texts appropriately, and are shown to subsequently perform well on classification tasks with small training sets. The overall classification model is a simple classifier on top of the pre-trained deep language model.Results: The models are evaluated on picture description test transcripts of the Pitt corpus, which contains data of 170 AD patients with 257 interviews and 99 healthy controls with 243 interviews. The large bidirectional encoder representations from transformers (BERTLarge) embedding with logistic regression classifier achieves classification accuracy of 88.08%, which improves the state-of-the-art by 2.48%.Conclusions: Using pre-trained language models can improve AD prediction. This not only solves the problem of lack of sufficiently large datasets, but also reduces the need for expert-defined features.

1 July 2020 in Journal of Neuroscience Methods
Verified
Journal Article
Closed access
KEKiana Ezzatdoost
Kiana Ezzatdoost
HHHadi Hojjati
Hadi Hojjati
HAHamid Aghajan
Hamid Aghajan

7 June 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MLMojtaba Lahijanian
Mojtaba Lahijanian
HAHamid Aghajan
Hamid Aghajan
ZVZahra Vahabi
Zahra Vahabi
Dementia, and in particular Alzheimer’s disease (AD), can be characterized by disrupted functional connectivity in the brain caused by beta-amyloid deposition in neural links. Non-pharmaceutical treatments for dementia have recently explored interventions involving the stimulation of neuronal populations in the gamma band. These interventions aim to restore brain network functionality by synchronizing rhythmic energy through various stimulation modalities. Entrainment, a newly proposed non-invasive sensory stimulation method, has shown promise in improving cognitive functions in dementia patients. This study investigates the effectiveness of entrainment in terms of promoting neural synchrony and spatial connectivity across the cortex. EEG signals were recorded during a 40 Hz auditory entrainment session conducted with a group of elderly participants with dementia. Phase locking value (PLV) between different intraregional and interregional sites was examined as an attribute of network synchronization, and connectivity of local and distant links were compared during the stimulation and rest trials. Our findings demonstrate enhanced neural synchrony between the frontal and parietal regions, which are key components of the brain’s default mode network (DMN). The DMN operation is known to be impacted by dementia’s progression, leading to reduced functional connectivity across the parieto-frontal pathways. Notably, entrainment alone significantly improves synchrony between these DMN components, suggesting its potential for restoring functional connectivity.

15 December 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MSMohammad Javad Sedghizadeh
Mohammad Javad Sedghizadeh
HHHadi Hojjati
Hadi Hojjati
KEKiana Ezzatdoost
Kiana Ezzatdoost
HAHamid Aghajan
Hamid Aghajan
ZVZahra Vahabi
Zahra Vahabi
HTHeliya Tarighatnia
Heliya Tarighatnia
High-frequency oscillations of the frontal cortex are involved in functions of the brain that fuse processed data from different sensory modules or bind them with elements stored in the memory. These oscillations also provide inhibitory connections to neural circuits that perform lower-level processes. Deficit in the performance of these oscillations has been examined as a marker for Alzheimer’s disease (AD). Additionally, the neurodegenerative processes associated with AD, such as the deposition of amyloid-beta plaques, do not occur in a spatially homogeneous fashion and progress more prominently in the medial temporal lobe in the early stages of the disease. This region of the brain contains neural circuitry involved in olfactory perception. Several studies have suggested that olfactory deficit can be used as a marker for early diagnosis of AD. A quantitative assessment of the performance of the olfactory system can hence serve as a potential biomarker for Alzheimer’s disease, offering a relatively convenient and inexpensive diagnosis method. This study examines the decline in the perception of olfactory stimuli and the deficit in the performance of high-frequency frontal oscillations in response to olfactory stimulation as markers for AD. Two measurement modalities are employed for assessing the olfactory performance: 1) An interactive smell identification test is used to sample the response to a sizable variety of odorants, and 2) Electroencephalography data are collected in an olfactory perception task with a pair of selected odorants in order to assess the connectivity of frontal cortex regions. Statistical analysis methods are used to assess the significance of selected features extracted from the recorded modalities as Alzheimer’s biomarkers. Olfactory decline regressed to age in both healthy and mild AD groups are evaluated, and single- and multi-modal classifiers are also developed. The novel aspects of this study include: 1) Combining EEG response to olfactory stimulation with behavioral assessment of olfactory perception as a marker of AD, 2) Identification of odorants most significantly affected in mild AD patients, 3) Identification of odorants which are still adequately perceived by mild AD patients, 4) Analysis of the decline in the spatial coherence of different oscillatory bands in response to olfactory stimulation, and 5) Being the first study to quantitatively assess the performance of olfactory decline due to aging and AD in the Iranian population.

23 August 2022 in Brain Structure and Function
Verified
Journal Article
Closed access
PDF file
MSMohammad Javad Sedghizadeh
Mohammad Javad Sedghizadeh
HAHamid Aghajan
Hamid Aghajan
ZVZahra Vahabi
Zahra Vahabi
SFSeyyedeh Nahaleh Fatemi
Seyyedeh Nahaleh Fatemi
AAArshia Afzal
Arshia Afzal

3 June 2023 in Data in Brief
Verified
Journal Article
Open access
MSMohammad Javad Sedghizadeh
Mohammad Javad Sedghizadeh
HAHamid Aghajan
Hamid Aghajan
ZVZahra Vahabi
Zahra Vahabi
The dataset presented in this article contains preprocessed cleaned electroencephalography (EEG) recording from 35 participants including 13 Alzheimer's disease (AD) patients, 7 amnestic mild cognitive impairment (aMCI) patients, and 15 healthy elderly. All participants performed the same olfactory task which consisted of 120 trials of 2 s olfactory stimulation and 8 s rest (no odorant). The olfactory stimulation consisted of rose and lemon odorants. Odor trials were presented randomly with a probability of 0.75 presenting lemon and 0.25 presenting rose. The impedance of the electrodes was kept under 15 KΩ during the experiment. The data was filtered from 0.5 to 40 Hz using a bandpass filter and epoched from 1 s pre-stimulus to 2 s post-stimulus. Artifacts related to eye blinks were removed by running independent component analysis (ICA) and the remaining noisy trials were identified by eye and removed from further analysis. Mini Mental State Examination (MMSE) test scores for all participants are also provided in the dataset. Olfactory dysfunction has been shown to be associated with neurodegenerative diseases such as dementia and Alzheimer's disease. Therefore, studying the response of the olfactory system may lead to identifying early biomarkers for related brain disorders.